GO:1900273 positive regulation of long-term synaptic potentiation: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900273 describes any process that activates or increases the frequency, rate or extent of long-term synaptic potentiation (LTP), a persistent strengthening of synaptic transmission widely studied as a cellular correlate of learning and memory.
• Positive regulation of LTP requires coordinated activation of postsynaptic glutamate receptors, especially NMDA receptors, and downstream signal amplification that converts brief synaptic input into durable changes in synaptic strength.
• Small GTPase signaling, including Rac1 and its regulators BCR and ABR, controls actin dynamics and LTP maintenance, linking structural plasticity to memory persistence.
• Neuregulin 1 and ErbB4 signaling in parvalbumin-positive interneurons critically regulates hippocampal LTP, showing that positive regulation of LTP depends on both excitatory and inhibitory circuit components.
• Stochastic and homeostatic mechanisms, including activity-induced resetting driven by LARGE protein, shape whether LTP is induced and maintained, so positive regulation is not a simple linear switch.
• Dysregulation of LTP-positive regulatory pathways is implicated in anxiety-related behaviors, post-traumatic stress disorder, and cognitive dysfunction, making these pathways attractive for mechanistic and translational research.
Description
Long-term synaptic potentiation (LTP) is a form of activity-dependent synaptic plasticity that has been studied for decades as a leading cellular model of learning and memory. GO:1900273, positive regulation of long-term synaptic potentiation, captures the biological processes that activate or increase the frequency, rate or extent of LTP, rather than LTP itself. This distinction matters because many signaling pathways, receptors, and structural proteins do not simply permit LTP but actively drive it forward, amplify it, or stabilize it over time. Researchers studying synaptic plasticity, memory, and neuropsychiatric disease therefore need a precise ontology term for the positive regulatory arm of LTP. GO:1900273 provides that term, grouping diverse molecular events such as NMDA receptor signal amplification, Rac1-dependent cytoskeletal remodeling, and interneuron-mediated disinhibition under a single biological_process node. Because LTP is not a single molecule or a single step, positive regulation of LTP is best understood as an emergent property of multiple interacting mechanisms. These include glutamate receptor activation, intracellular calcium signaling, small GTPase activity, and homeostatic feedback that resets synaptic strength after activity. This article summarizes the authoritative GO definition, the major mechanistic stages, key genes and proteins, disease relevance, and experimental methods used to study positive regulation of long-term synaptic potentiation.
positive regulation of long-term synaptic potentiation At A Glance
| GO ID | GO:1900273 |
|---|---|
| GO term | positive regulation of long-term synaptic potentiation |
| Ontology | biological_process |
| Synonym | activation of long-term potentiation; activation of LTP; positive regulation of LTP; upregulation of long-term synaptic potentiation |
| Major function | Activates or increases the frequency, rate or extent of long-term synaptic potentiation (LTP) |
| Related process | Long-term synaptic potentiation (LTP), a persistent activity-dependent increase in synaptic strength |
| Key molecular players | NMDA receptors, Rac1 GTPase and its regulators BCR/ABR, neuregulin 1 and ErbB4 |
| Circuit context | Hippocampal and cortical excitatory and inhibitory circuits, including parvalbumin-positive interneurons |
| Disease relevance | Anxiety-related behaviors, post-traumatic stress disorder, and cognitive dysfunction |
What Is GO:1900273?
According to the Gene Ontology, GO:1900273 (positive regulation of long-term synaptic potentiation) is defined as any process that activates or increases the frequency, rate or extent of long-term synaptic potentiation. In other words, it is the positive regulatory counterpart to LTP itself: it does not describe the strengthening of a synapse directly, but rather the upstream or parallel processes that promote, enhance, or sustain that strengthening. The term belongs to the biological_process aspect of GO and includes synonyms such as activation of LTP, positive regulation of LTP, and upregulation of long-term synaptic potentiation. Because the definition is regulatory rather than structural, GO:1900273 can be assigned to many different molecular mechanisms, including receptor signaling, kinase cascades, cytoskeletal reorganization, and circuit-level disinhibition, as long as the downstream outcome is increased LTP.
Why Is positive regulation of long-term synaptic potentiation Important in Cell Biology?
Positive regulation of long-term synaptic potentiation is important because LTP is one of the most widely studied cellular correlates of learning and memory, and the positive regulatory processes that drive LTP determine whether a synapse strengthens, how long that strengthening lasts, and how it interacts with behavior. Disruptions in these regulatory pathways have been linked to anxiety-related behaviors, stress-related disorders, and cognitive impairment, making GO:1900273 a useful entry point for researchers who want to move from a candidate gene or signaling pathway to a mechanistic hypothesis about memory and disease. Because the term is regulatory rather than descriptive, it also helps experimentalists design loss-of-function and gain-of-function studies that ask whether a gene is necessary or sufficient for LTP, rather than merely correlated with it.
• Provides a precise ontology label for processes that enhance or sustain LTP, distinct from LTP itself.
• Links molecular signaling, such as NMDA receptor amplification and Rac1 GTPase activity, to memory-related synaptic strengthening.
• Highlights the role of inhibitory interneurons and neuregulin 1/ErbB4 signaling in gating LTP.
• Supports mechanistic studies of anxiety-related behaviors and stress-related disorders where hippocampal plasticity is altered.
• Helps interpret stochastic and homeostatic effects that determine whether LTP is induced and maintained.
• Guides experimental design for knockout, knock-in, and overexpression models of LTP-regulating genes.
• Connects synaptic plasticity research to translational questions in neuropsychiatric disease.
• Provides a framework for comparing positive versus negative regulation of LTP in the same circuit.
What Happens During positive regulation of long-term synaptic potentiation?
Initiation by glutamate receptor activation and calcium entry
In simple terms: The process starts when strong synaptic activity activates glutamate receptors and lets calcium into the postsynaptic neuron.
Positive regulation of LTP typically begins with strong or repeated synaptic stimulation that activates postsynaptic glutamate receptors, especially NMDA receptors, leading to calcium influx and the triggering of intracellular signaling cascades. Signal amplification of NMDA receptor responses is a key early event that helps convert brief synaptic input into a sustained biochemical signal capable of supporting LTP. This initiation step is not merely permissive; it is actively regulated, and the magnitude of receptor activation helps determine whether LTP is induced.
Downstream signaling and cytoskeletal remodeling
In simple terms: Once calcium enters, signaling proteins reorganize the synapse's internal skeleton to make the connection stronger.
After initiation, positive regulation of LTP involves downstream signaling that modifies synaptic structure and function. Rac1 GTPase activity and its regulation by BCR and ABR Rac GTPase-activating proteins are required for LTP maintenance, learning, and memory, linking small GTPase signaling to actin cytoskeletal dynamics at synapses. This step illustrates that positive regulation of LTP is not only about receptor activity but also about structural remodeling that stabilizes synaptic strengthening over time.
Circuit-level gating by interneurons and neuregulin signaling
In simple terms: Inhibitory neurons can act as gatekeepers that either permit or block LTP, and signals like neuregulin 1 help set that gate.
Positive regulation of LTP is also controlled at the circuit level. ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation, indicating that interneuron-mediated disinhibition or modulation can positively regulate LTP. This means that the same synapse can be influenced by signals originating from inhibitory cells, and that positive regulation of LTP depends on the balance between excitation and inhibition in the local network.
Stochastic and homeostatic modulation of LTP induction
In simple terms: Whether LTP happens is partly a matter of chance and is also kept in check by homeostatic mechanisms that reset activity.
Positive regulation of LTP is not deterministic. Stochastic induction of LTP and long-term depression means that identical stimulation patterns can produce different outcomes depending on molecular noise and state. In addition, activity-induced homeostatic resetting driven by LARGE protein can counteract or reshape plasticity, showing that positive regulation must be understood alongside negative feedback and homeostatic control. These findings help explain why positive regulation of LTP is best modeled as a dynamic, state-dependent process rather than a simple on/off switch.
Key Genes Involved in GO:1900273 positive regulation of long-term synaptic potentiation
The following genes and proteins have been experimentally linked to positive regulation of long-term synaptic potentiation or to closely related LTP-regulatory mechanisms in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GRIN1 | NMDA receptor subunit involved in glutamate receptor signaling and calcium influx during LTP induction | Core target for studying signal amplification of NMDA receptors in LTP |
| GRIN2A | NMDA receptor subunit contributing to synaptic plasticity and LTP-related signaling | Candidate for point-mutation and electrophysiology studies of LTP |
| GRIN2B | NMDA receptor subunit implicated in long-term synaptic plasticity | Model for receptor subunit contributions to positive regulation of LTP |
| RAC1 | Small GTPase regulating synaptic Rac1 activity and LTP maintenance | Key node for knockout and knock-in studies of LTP maintenance |
| BCR | Rac GTPase-activating protein regulating Rac1 and LTP maintenance | Loss-of-function models to test necessity in LTP and memory |
| ABR | Rac GTPase-activating protein cooperating with BCR in LTP regulation | Double-knockout and rescue experiments for LTP maintenance |
| NRG1 | Neuregulin 1 ligand regulating LTP via ErbB4 signaling | Ligand-side manipulation of positive LTP regulation |
| ERBB4 | Receptor in parvalbumin-positive interneurons critical for neuregulin 1 regulation of LTP | Cell-type-specific knockout to test interneuron gating of LTP |
| PVALB | Parvalbumin-positive interneuron marker defining the cell type where ErbB4 acts | Used to target and identify interneurons in LTP studies |
| LARGE1 | Protein involved in activity-induced homeostatic resetting that shapes plasticity | Model for homeostatic control of positive LTP regulation |
| GABRA1 | GABA-A receptor subunit relevant to inhibitory control of hippocampal plasticity | Target for studying excitatory-inhibitory balance in LTP |
| GABRB1 | GABA-A receptor subunit contributing to inhibitory synaptic transmission | Candidate for circuit-level LTP regulation studies |
| GLRA1 | Glycine receptor subunit linked to excitatory glycine receptor control of ventral hippocampus plasticity | Model for non-glutamatergic control of LTP-related plasticity |
| GLRB1 | Glycine receptor subunit involved in ventral hippocampus synaptic plasticity | Target for receptor-level manipulation of plasticity |
| CAMK2A | Calcium/calmodulin-dependent kinase implicated in LTP-related signaling | Classic kinase target for LTP mechanism studies |
| ARC | Activity-regulated cytoskeleton-associated protein involved in synaptic plasticity | Readout of activity-dependent synaptic remodeling |
| BDNF | Neurotrophin supporting synaptic plasticity and LTP-related processes | Candidate for overexpression and rescue experiments |
| CREB1 | Transcription factor linked to long-term synaptic plasticity and memory | Target for studying transcriptional control of LTP maintenance |
How Is positive regulation of long-term synaptic potentiation Regulated?
Positive regulation of long-term synaptic potentiation is itself regulated at multiple levels. At the receptor level, NMDA receptor signal amplification controls the strength of the initial trigger for LTP. At the signaling level, Rac1 activity is regulated by BCR and ABR Rac GTPase-activating proteins, which are required for LTP maintenance and memory. At the circuit level, neuregulin 1 acting through ErbB4 in parvalbumin-positive interneurons regulates LTP, showing that inhibitory networks can gate positive regulation. In addition, stochastic induction mechanisms and activity-induced homeostatic resetting driven by LARGE protein provide feedback that can limit or reshape LTP. Together, these layers of regulation mean that positive regulation of LTP is a dynamic process influenced by receptor state, intracellular signaling, circuit activity, and homeostatic feedback.
positive regulation of long-term synaptic potentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GRIN1 | Cognitive dysfunction and synaptic plasticity disorders | Knockout or point-mutation models with electrophysiology |
| RAC1 | Memory and LTP maintenance defects | Conditional knockout and rescue in hippocampus |
| ERBB4 | Anxiety-related and circuit-level plasticity disorders | Parvalbumin-positive interneuron-specific knockout |
| LARGE1 | Homeostatic plasticity dysregulation | Overexpression and activity-resetting paradigms |
| GLRA1 | Anxiety-related behaviors and ventral hippocampus plasticity | Knockout or knock-in with behavioral testing |
Anxiety-related behaviors and stress-related disorders
Excitatory glycine receptors control ventral hippocampus synaptic plasticity and anxiety-related behaviors, linking plasticity-regulatory mechanisms to anxiety. Transcutaneous auricular vagus nerve stimulation alleviates anxiety-like behaviors in mice with post-traumatic stress disorder by regulating glutamatergic neurons in the anterior cingulate cortex, further connecting LTP-related plasticity to stress-related disorders. These studies suggest that positive regulation of long-term synaptic potentiation is relevant to the pathophysiology of anxiety and PTSD-like states.
Cognitive dysfunction and memory disorders
Because LTP is a widely used cellular correlate of learning and memory, disruption of its positive regulation is expected to impair memory-related processes. Rac1 signaling through BCR and ABR is required for LTP maintenance, learning, and memory, so perturbations in this pathway may contribute to cognitive dysfunction. Neuregulin 1/ErbB4 regulation of LTP in interneurons also highlights how circuit-level changes can affect cognitive function.
Homeostatic dysregulation and plasticity-related disease
Activity-induced homeostatic resetting driven by LARGE protein shapes plasticity and may be relevant when homeostatic control fails. Stochastic induction of LTP and LTD means that disease-related changes in molecular noise or state could alter the probability of synaptic strengthening. These mechanisms are relevant to conditions where plasticity is either excessive or insufficient, although direct disease links remain an active area of research.
From positive regulation of long-term synaptic potentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene necessary for positive regulation of LTP? | Knockout cell or animal model with LTP electrophysiology |
| Does a specific amino acid change alter LTP regulation? | Point-mutation knock-in model |
| Can a disease-associated variant affect LTP? | Knock-in of the variant with synaptic plasticity assays |
| Where and when is a protein expressed during LTP? | Tagged knock-in with imaging or proteomics |
| Is increased gene dosage sufficient to enhance LTP? | Overexpression model with LTP recordings |
| Which cell type mediates the effect? | Cell-type-specific Cre or intersectional knockout |
How to Study the positive regulation of long-term synaptic potentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Field electrophysiology | Changes in synaptic strength after stimulation | Testing positive regulation of LTP in hippocampal slices |
| Whole-cell patch clamp | Synaptic currents and receptor function | Mechanistic studies of NMDA receptor amplification |
| Rac1 activity assay | Small GTPase activation state | Testing BCR/ABR regulation of LTP maintenance |
| Cell-type-specific knockout | Gene function in defined neurons | Interneuron gating of LTP via ErbB4 |
| Behavioral testing | Anxiety-like and memory-related behaviors | Linking LTP regulation to disease-relevant phenotypes |
| Stochastic modeling | Probability of LTP induction | Explaining variability in plasticity outcomes |
| Homeostatic resetting assays | Activity-induced changes in synaptic state | Studying LARGE-dependent plasticity resetting |
| Imaging of synaptic structure | Spine and synapse morphology | Connecting cytoskeletal remodeling to LTP |
Electrophysiology for LTP measurement
Field and whole-cell electrophysiology remain the gold standard for measuring long-term synaptic potentiation and its positive regulation. These methods allow researchers to test whether a genetic or pharmacological manipulation increases the frequency, rate, or extent of LTP.
Molecular signaling assays
Biochemical assays for small GTPase activity, receptor phosphorylation, and downstream kinase signaling help define the molecular steps that positively regulate LTP. Rac1 activity assays, for example, can reveal how BCR and ABR regulate LTP maintenance.
Circuit and cell-type-specific manipulations
Cell-type-specific tools, such as targeting ErbB4 in parvalbumin-positive interneurons, allow researchers to dissect circuit-level positive regulation of LTP. Behavioral assays combined with plasticity measurements can then link these mechanisms to anxiety-related or memory-related outcomes.
Homeostatic and stochastic modeling
Computational and stochastic models help explain why identical stimulation can produce different LTP outcomes and how homeostatic resetting shapes plasticity. These approaches complement experimental work by generating testable predictions about positive regulation of LTP.
How CRISPR Can Be Used to Study GO:1900273 positive regulation of long-term synaptic potentiation
Knockout
CRISPR knockout models are used to test whether a candidate gene is necessary for positive regulation of long-term synaptic potentiation. For example, knocking out Rac1 regulators such as BCR and ABR can reveal their requirement for LTP maintenance and memory. Cell-type-specific knockout of ErbB4 in parvalbumin-positive interneurons can test circuit-level necessity.
Point Mutation
Point-mutation models allow precise testing of amino acid residues involved in LTP-regulatory signaling. For instance, mutations in NMDA receptor subunits can be introduced to study signal amplification and calcium-dependent signaling during LTP. Such models help distinguish domain-specific functions from whole-protein loss-of-function effects.
Knock-in
Knock-in models can introduce disease-associated variants or tags into endogenous loci to study positive regulation of LTP in a physiological context. Tagged knock-in of synaptic proteins enables imaging and proteomic analysis of their dynamics during plasticity. Variant knock-in can test whether a specific human variant alters LTP regulation.
Overexpression
Overexpression models test whether increasing the dosage of a gene is sufficient to enhance positive regulation of LTP. Overexpressing neurotrophins or signaling molecules can increase synaptic strength and plasticity-related readouts. These models complement knockout studies by addressing sufficiency rather than necessity.
How EDITGENE Supports positive regulation of long-term synaptic potentiation Research
Researchers studying positive regulation of long-term synaptic potentiation-related genes often need to determine whether a candidate gene is causally involved in enhancing or sustaining LTP, rather than merely correlated with it. This requires well-controlled genetic models that can test necessity, sufficiency, and domain-specific function in relevant neuronal circuits. EDITGENE provides CRISPR-based tools and services designed to support these mechanistic studies, from single-gene knockout to precise point mutations and knock-in reporters.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of long-term synaptic potentiation research.
Frequently Asked Questions About positive regulation of long-term synaptic potentiation
What is GO:1900273 positive regulation of long-term synaptic potentiation?
GO:1900273 is a Gene Ontology biological_process term defined as any process that activates or increases the frequency, rate or extent of long-term synaptic potentiation (LTP).
What genes are involved in positive regulation of long-term synaptic potentiation?
Genes implicated in this process include GRIN1, GRIN2A, GRIN2B, RAC1, BCR, ABR, NRG1, ERBB4, and LARGE1, based on experimental studies of LTP regulation.
How is long-term synaptic potentiation positively regulated?
Positive regulation occurs through glutamate receptor activation and signal amplification, downstream small GTPase signaling and cytoskeletal remodeling, circuit-level gating by interneurons, and modulation by stochastic and homeostatic mechanisms.
What is the role of Rac1 in LTP maintenance?
Rac1 GTPase activity, regulated by BCR and ABR Rac GTPase-activating proteins, is required for LTP maintenance, learning, and memory.
How do interneurons regulate long-term potentiation?
ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation, showing that inhibitory circuits can gate positive regulation of LTP.
Is LTP induction stochastic?
Yes, stochastic induction of long-term potentiation and long-term depression has been demonstrated, meaning identical stimulation can produce different outcomes depending on molecular state.
What is the role of LARGE protein in synaptic plasticity?
LARGE protein drives activity-induced homeostatic resetting, which shapes plasticity and provides feedback on positive regulation of LTP.
Which diseases are linked to dysregulated LTP?
Dysregulated LTP-related mechanisms have been linked to anxiety-related behaviors, post-traumatic stress disorder, and cognitive dysfunction in preclinical studies.
What methods are used to study positive regulation of LTP?
Common methods include electrophysiology, molecular signaling assays, cell-type-specific manipulations, behavioral testing, and computational modeling.
How can CRISPR help study positive regulation of long-term synaptic potentiation?
CRISPR knockout, point-mutation, knock-in, and overexpression models allow researchers to test necessity, sufficiency, and domain-specific functions of genes involved in LTP regulation.
Conclusion
GO:1900273, positive regulation of long-term synaptic potentiation, provides a precise ontology framework for studying the processes that enhance or sustain LTP. Experimental evidence implicates NMDA receptor signaling, Rac1 GTPase regulation, neuregulin 1/ErbB4 interneuron signaling, and homeostatic mechanisms in this positive regulation. These pathways are relevant to anxiety-related behaviors, stress-related disorders, and cognitive function, making them important targets for mechanistic and translational research. CRISPR-based models offer a powerful way to test causality and refine our understanding of how positive regulation of LTP is controlled.
References
- 2. Pizzamiglio L et al.. 2025. Excitatory glycine receptors control ventral hippocampus synaptic plasticity and anxiety-related behaviors.. Proc Natl Acad Sci U S A 122(37):e2501118122 PMID: 40924452
- 3. MacDonald JF et al.. 2006. Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors.. Crit Rev Neurobiol 18(1-2):71-84 PMID: 17725510
- 4. Antunes G et al.. 2016. Stochastic Induction of Long-Term Potentiation and Long-Term Depression.. Sci Rep 6:30899 PMID: 27485552
- 5. Diao Z et al.. 2025. Transcutaneous auricular vagus nerve stimulation alleviates anxiety-like behaviors in mice with post-traumatic stress disorder by regulating glutamatergic neurons in the anterior cingulate cortex.. Transl Psychiatry 15(1):313 PMID: 40849423
- 6. Oh D et al.. 2010. Regulation of synaptic Rac1 activity, long-term potentiation maintenance, and learning and memory by BCR and ABR Rac GTPase-activating proteins.. J Neurosci 30(42):14134-44 PMID: 20962234
- 7. Chen YJ et al.. 2010. ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation.. Proc Natl Acad Sci U S A 107(50):21818-23 PMID: 21106764
- 8. Seo BA et al.. 2025. LARGE protein drives activity-induced homeostatic resetting.. Sci Adv 11(31):eadt0703 PMID: 40737424
